No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antineoplastic Agents / therapeutic use*
-
Benzamides / therapeutic use*
-
Feasibility Studies
-
Female
-
Fluorodeoxyglucose F18
-
Follow-Up Studies
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / pathology
-
Gastrointestinal Stromal Tumors / secondary*
-
Humans
-
Imatinib Mesylate
-
Magnetic Resonance Imaging
-
Male
-
Middle Aged
-
Multimodal Imaging*
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Piperazines / therapeutic use*
-
Positron-Emission Tomography
-
Pyrimidines / therapeutic use*
-
Radiopharmaceuticals
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Benzamides
-
Piperazines
-
Pyrimidines
-
Radiopharmaceuticals
-
Fluorodeoxyglucose F18
-
Imatinib Mesylate
Associated data
-
ClinicalTrials.gov/NCT01276483